Clinical implications of
Aged
Aortic Valve
/ diagnostic imaging
Aortic Valve Stenosis
/ complications
Calcinosis
/ complications
Coronary Artery Disease
/ complications
Female
Fluorine Radioisotopes
/ pharmacokinetics
Humans
Male
Middle Aged
Positron-Emission Tomography
Predictive Value of Tests
Radiopharmaceuticals
/ pharmacokinetics
Retrospective Studies
Sodium Fluoride
/ pharmacokinetics
Tomography, X-Ray Computed
CT
PET
Valvular heart disease
metabolism imaging agents
Journal
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
ISSN: 1532-6551
Titre abrégé: J Nucl Cardiol
Pays: United States
ID NLM: 9423534
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
received:
25
06
2019
accepted:
21
08
2019
pubmed:
5
9
2019
medline:
17
2
2022
entrez:
5
9
2019
Statut:
ppublish
Résumé
Uptake of We studied 25 patients with subclinical AVC and coronary plaques detected on computed tomography (CT) who underwent There were positive correlations between AVC TBR Our
Sections du résumé
BACKGROUND
Uptake of
METHODS
We studied 25 patients with subclinical AVC and coronary plaques detected on computed tomography (CT) who underwent
RESULTS
There were positive correlations between AVC TBR
CONCLUSION
Our
Identifiants
pubmed: 31482532
doi: 10.1007/s12350-019-01879-6
pii: 10.1007/s12350-019-01879-6
doi:
Substances chimiques
Fluorine Radioisotopes
0
Radiopharmaceuticals
0
Sodium Fluoride
8ZYQ1474W7
Fluorine-18
GZ5I74KB8G
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1522-1531Informations de copyright
© 2019. American Society of Nuclear Cardiology.
Références
Rosenhek R, Binder T, Porenta G, Lang I, Christ G, Schemper M, et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Eng J Med 2000;343:611-7.
doi: 10.1056/NEJM200008313430903
Hop H, de Boer SA, Reijrink M, Kamphuisen PW, de Borst MH, Pol RA, et al. 18F-sodium fluoride positron emission tomography assessed microcalcifications in culprit and non-culprit human carotid plaques. J Nucl Cardiol 2018;26:1064-75.
doi: 10.1007/s12350-018-1325-5
Dweck MR, Chow MW, Joshi NV, Williams MC, Jones C, Fletcher AM, et al. Coronary arterial 18F-sodium fluoride uptake: A novel marker of plaque biology. J Am Coll Cardiol 2012;59:1539-48.
doi: 10.1016/j.jacc.2011.12.037
Dweck MR, Jones C, Joshi NV, Fletcher AM, Richardson H, White A, et al. Assessment of valvular calcification and inflammation by positron emission tomography in patients with aortic stenosis. Circulation 2012;125:76-86.
doi: 10.1161/CIRCULATIONAHA.111.051052
Aikawa E, Nahrendorf M, Figueiredo JL, Swirski FK, Shtatland T, Kohler RH, et al. Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo. Circulation 2007;116:2841-50.
doi: 10.1161/CIRCULATIONAHA.107.732867
New SE, Goettsch C, Aikawa M, Marchini JF, Shibasaki M, Yabusaki K, et al. Macrophage-derived matrix vesicles: An alternative novel mechanism for microcalcification in atherosclerotic plaques. Circ Res 2013;113:72-7.
doi: 10.1161/CIRCRESAHA.113.301036
Dweck MR, Boon NA, Newby DE. Calcific aortic stenosis: A disease of the valve and the myocardium. J Am Coll Cardiol 2012;60:1854-63.
doi: 10.1016/j.jacc.2012.02.093
Dweck MR, Jenkins WS, Vesey AT, Pringle MA, Chin CW, Malley TS, et al. 18F-sodium fluoride uptake is a marker of active calcification and disease progression in patients with aortic stenosis. Circ Cardiovasc Imaging 2014;7:371-8.
doi: 10.1161/CIRCIMAGING.113.001508
Kitagawa T, Yamamoto H, Toshimitsu S, Sasaki K, Senoo A, Kubo Y, et al. 18F-sodium fluoride positron emission tomography for molecular imaging of coronary atherosclerosis based on computed tomography analysis. Atherosclerosis 2017;263:385-92.
doi: 10.1016/j.atherosclerosis.2017.04.024
Kitagawa T, Yamamoto H, Nakamoto Y, Sasaki K, Toshimitsu S, Tatsugami F, et al. Predictive value of 18F-sodium fluoride positron emission tomography in detecting high-risk coronary artery disease in combination with computed tomography. J Am Heart Assoc 2018;7:e010224.
doi: 10.1161/JAHA.118.010224
Raff GL, Abidov A, Achenbach S, Berman DS, Boxt LM, Budoff MJ, et al. SCCT guidelines for the interpretation and reporting of coronary computed tomographic angiography. J Cardiovasc Comput Tomogr 2009;3:122-36.
doi: 10.1016/j.jcct.2009.01.001
Allison MA, Cheung P, Criqui MH, Langer RD, Wright CM. Mitral and aortic annular calcification are highly associated with systemic calcified atherosclerosis. Circulation 2006;113:861-6.
doi: 10.1161/CIRCULATIONAHA.105.552844
Motoyama S, Kondo T, Sarai M, Sugiura A, Harigaya H, Sato T, et al. Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes. J Am Coll Cardiol 2007;50:319-26.
doi: 10.1016/j.jacc.2007.03.044
Motoyama S, Sarai M, Harigaya H, Anno H, Inoue K, Hara T, et al. Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. J Am Coll Cardiol 2009;54:49-57.
doi: 10.1016/j.jacc.2009.02.068
Mohler ER 3rd, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS. Bone formation and inflammation in cardiac valves. Circulation 2001;103:1522-8.
doi: 10.1161/01.CIR.103.11.1522
Rajamannan NM, Subramaniam M, Rickard D, Stock SR, Donovan J, Springett M, et al. Human aortic valve calcification is associated with an osteoblast phenotype. Circulation 2003;107:2181-4.
doi: 10.1161/01.CIR.0000070591.21548.69
Aksoy Y, Yagmur C, Tekin GO, Yagmur J, Topal E, Kekilli E, et al. Aortic valve calcification: Association with bone mineral density and cardiovascular risk factors. Coron Artery Dis 2005;16:379-83.
doi: 10.1097/00019501-200509000-00007
O’Brien KD, Reichenbach DD, Marcovina SM, Kuusisto J, Alpers CE, Otto CM. Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of ‘degenerative’ valvular aortic stenosis. Arterioscler Thromb Vasc Biol 1996;16:523-32.
doi: 10.1161/01.ATV.16.4.523
Olsson M, Thyberg J, Nilsson J. Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves. Arterioscler Thromb Vasc Biol 1999;19:1218-22.
doi: 10.1161/01.ATV.19.5.1218
Otto CM, Kuusisto J, Reichenbach DD, Gown AM, O’Brien KD. Characterization of the early lesion of ‘degenerative’ valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 1994;90:844-53.
doi: 10.1161/01.CIR.90.2.844
Messika-Zeitoun D, Bielak LF, Peyser PA, Sheedy PF, Turner ST, Enriquez-Sarano M, et al. Aortic valve calcification: Determinants and progression in the population. Arterioscler Thromb Vasc Biol 2007;27(3):642-8.
doi: 10.1161/01.ATV.0000255952.47980.c2
Dweck MR, Khaw HJ, Sng GK, Luo EL, Baird A, Williams MC, et al. Aortic stenosis, atherosclerosis, and skeletal bone: Is there a common link with calcification and inflammation? Eur Heart J 2013;34:1567-74.
doi: 10.1093/eurheartj/eht034
Jenkins WS, Vesey AT, Shah AS, Pawade TA, Chin CW, White AC, et al. Valvular (18)F-fluoride and (18)F-fluorodeoxyglucose uptake predict disease progression and clinical outcome in patients with aortic stenosis. J Am Coll Cardiol 2015;66:1200-1.
doi: 10.1016/j.jacc.2015.06.1325
Beheshti M, Saboury B, Mehta NN, Torigian DA, Werner T, Mohler E, et al. Detection and global quantification of cardiovascular molecular calcification by fluoro18-fluoride positron emission tomography/computed tomography—A novel concept. Hell J Nucl Med 2011;14:114-20.
pubmed: 21761011
Kwiecinski J, Adamson PD, Lassen ML, Doris MK, Moss AJ, Cadet S, et al. Feasibility of coronary 18F-sodium fluoride positron-emission tomography assessment with the utilization of previously acquired computed tomography angiography. Circ Cardiovasc Imaging 2018;11:e008325.
doi: 10.1161/CIRCIMAGING.118.008325
Pawade TA, Cartlidge TR, Jenkins WS, Adamson PD, Robson P, Lucatelli C, et al. Optimization and reproducibility of aortic valve 18F-fluoride positron emission tomography in patients with aortic stenosis. Circ Cardiovasc Imaging 2016;9:e005131.
doi: 10.1161/CIRCIMAGING.116.005131
Massera D, Doris MK, Cadet S, Kwiecinski J, Pawade TA, Peeters FECM, et al. Analytical quantification of aortic valve 18F-sodium fluoride PET uptake. J Nucl Cardiol 2019. https://doi.org/10.1007/s12350-018-01542-6 .
doi: 10.1007/s12350-018-01542-6
Cal-Gonzalez J, Li X, Heber D, Rausch I, Moore SC, Schäfers K, et al. Partial volume correction for improved PET quantification in 18F-NaF imaging of atherosclerotic plaques. J Nucl Cardiol 2018;25:1742-56.
doi: 10.1007/s12350-017-0778-2
Cowell SJ, Newby DE, Prescott RJ, Bloomfield P, Reid J, Northridge DB, et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Eng J Med 2005;352:2389-97.
doi: 10.1056/NEJMoa043876
Rossebø AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Eng J Med 2008;359:1343-56.
doi: 10.1056/NEJMoa0804602
Rajamannan NM, Subramaniam M, Stock SR, Stone NJ, Springett M, Ignatiev KI, et al. Atorvastatin inhibits calcification and enhances nitric oxide synthase production in the hypercholesterolaemic aortic valve. Heart 2005;91:806-10.
doi: 10.1136/hrt.2003.029785